Records 1 - 4
| Exploratory analysis of biomarkers associated with clinical outcomes from the study of lenvatinib in differentiated cancer of the thyroid.
European journal of cancer (Oxford, England : 1990) 2017 Feb 75 213-221.
Tahara Makoto, Schlumberger Martin, Elisei Rossella, Habra Mouhammed Amir, Kiyota Naomi, Paschke Ralf, Dutcus Corina E, Hihara Taro, McGrath Shannon, Matijevic Mark, Kadowaki Tadashi, Funahashi Yasuhiro, Sherman Steven
| Ecto-5' -Nucleotidase CD73 (NT5E), vitamin D receptor and FGF23 gene polymorphisms may play a role in the development of calcific uremic arteriolopathy in dialysis patients - Data from the German Calciphylaxis Registry.
PloS one 2017 12 (2): e0172407.
Rothe Hansjörg, Brandenburg Vincent, Haun Margot, Kollerits Barbara, Kronenberg Florian, Ketteler Markus, Wanner Christo
| Genetic variants in the fibroblast growth factor pathway as potential markers of ovarian cancer risk, therapeutic response, and clinical outcome.
Clinical chemistry 2014 Jan 60 (1): 222-32.
Meng Qing H, Xu Enping, Hildebrandt Michelle A T, Liang Dong, Lu Karen, Ye Yuanqing, Wagar Elizabeth A, Wu Xife
| Single nucleotide polymorphisms in fibroblast growth factor 23 gene, FGF23, are associated with prostate cancer risk.
BJU international 2013 Jul .
Kim HJ, Kim KH, Lee J, Oh JJ, Cheong HS, Wong EL, Yang BS, Byun SS, Myung SC